Alnylam Pharmaceuticals
ALNY
#584
Rank
S$45.02 B
Marketcap
$347.87
Share price
-2.24%
Change (1 day)
70.43%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company